Wall teichoic acids (WTAs) are phosphate-rich, sugar-based polymers attached to the cell walls of most Gram-positive bacteria. In Staphylococcus aureus, these anionic polymers regulate cell division, protect cells from osmotic stress, mediate host colonization, and mask enzymatically susceptible peptidoglycan bonds. Although WTAs are not required for survival in vitro, blocking the pathway at a late stage of synthesis is lethal. We recently discovered a novel antibiotic, targocil, that inhibits a late acting step in the WTA pathway. Its target is TarG, the transmembrane component of the ABC transporter (TarGH) that exports WTAs to the cell surface. We examined here the effects of targocil on S. aureus using transmission electron microscopy and gene expression profiling. We report that targocil treatment leads to multicellular clusters containing swollen cells displaying evidence of osmotic stress, strongly induces the cell wall stress stimulon, and reduces the expression of key virulence genes, including dlt-ABCD and capsule genes. We conclude that WTA inhibitors that act at a late stage of the biosynthetic pathway may be useful as antibiotics, and we present evidence that they could be particularly useful in combination with beta-lactams.
S
taphylococcus aureus is a pathogenic Gram-positive bacterium that is increasingly difficult to treat due to the rise of drug resistance (45, 60) . Many S. aureus strains are resistant to all betalactams, the most effective class of antibiotics in history (20, 59) . Some of these methicillin-resistant S. aureus (MRSA) strains have begun to acquire resistance to vancomycin, the drug of last resort (27, 59, 61) . Two new compound classes have been introduced to treat S. aureus infections since 2000, and the emergence of resistance to those is now a concern (40, 61) . Thus, novel compounds and strategies to overcome multiply resistant S. aureus infections are needed.
Wall teichoic acid (WTA) biosynthesis is a proposed new antibiotic target in S. aureus (70) . WTAs are phosphate-rich, sugarbased polymers that make up a large portion of the cell wall mass in many Gram-positive bacteria (4, 48) . In Bacillus subtilis, WTAs are critical for the maintenance of the rod-shaped morphology (14) . In S. aureus, WTAs play an important role in cell division and are required for establishing infections in animal hosts (10, 62, (67) (68) (69) .
S. aureus WTAs are synthesized on a bactoprenol carrier lipid on the inner leaflet of the cytoplasmic membrane (28) . In the first enzymatic step of WTA biosynthesis, TarO transfers an N-acetylglucosamine-1-phosphate (GlcNAc-phosphate) residue to bactoprenol phosphate to generate a GlcNAc-diphospholipid, which is transformed by the glycosyltransferase TarA into a lipidanchored disaccharide [ManNAc(␤1,4)GlcNAc] ( Fig. 1) (22) . The C4 hydroxyl of this disaccharide is primed with two glycerolphosphate units, and then 20 to 40 ribitol-phosphate repeats are added to form the main chain polymer (9) . The free hydroxyls on the ribitols are heavily modified with ␣-or ␤-O-GlcNAc residues (62) . The mature polymers are transported to the external surface of the bacterial membrane by a two-component ABC transporter, TarGH, and are subsequently attached to peptidoglycan (PG) by an unknown mechanism ( Fig. 1) (32) . The main chains are further tailored with D-alanyl esters, which affect their overall charge and increase resistance to cationic antibiotics (56) .
A striking feature of the WTA biosynthetic pathway is its mixed gene dispensability pattern (15, 62) . The first two genes in the pathway, tarO and tarA, are not required for in vitro growth; however, WTA deletion strains are nonpathogenic due to defects in host adhesion and dysregulated cell division (10, 13) . Hence, these early steps are proposed targets for anti-virulence factor agents. In contrast, most of the downstream genes cannot be deleted unless flux into the biosynthetic pathway is prevented (e.g., by deleting tarO) (15) . The conditional essentiality of the late acting genes is proposed to result from toxicity of accumulated intermediates and/or depletion of the bactoprenol-phosphate carrier lipid, which is also used for PG biosynthesis (66) . Therefore, the late, essential steps in the WTA biosynthetic pathway have been suggested as novel targets for antibiotics.
The natural product tunicamycin ( Fig. 1 ) is a selective inhibitor of TarO, which catalyzes the first step in the S. aureus WTA biosynthetic pathway, and we have previously characterized its cellular effects (10) . While tunicamycin has only a modest effect on cell growth and gene expression at concentrations that inhibit TarO, it profoundly alters cellular morphology. Like ⌬tarO strains, tunicamycin-treated cells have major defects in septal placement and other aspects of cell division. Since WTAs are necessary for the expression of beta-lactam resistance in MRSA, tunicamycin also resensitizes MRSA strains to this important family of antibiotics (10) . Hence, our previous studies have validated TarO as a promising target for novel anti-infectives for use alone or in combination with beta-lactams to treat S. aureus infections.
Here we characterize the effects on S. aureus of a specific inhibitor of one of the late, essential steps in the WTA biosynthetic pathway. The inhibitor, targocil, was discovered via highthroughput screening (36, 63) and shown to block TarG, the transmembrane component of the ABC transporter that exports WTA polymers to the cell surface (58, 63) . Deletion of tarO or inhibition of TarO by tunicamycin antagonizes the activity of targocil, consistent with the conditional essentiality of TarG (63) . We report here that TarG blockade by targocil has very different effects on S. aureus than TarO inhibition. Targocil inhibits bacterial growth, strongly induces the cell wall stress stimulon, and downregulates the expression of numerous virulence factors. Transmission electron microscopy (TEM) studies show morphological abnormalities, but they are distinct from those observed for tunicamycin and suggest a response to cell envelope damage and osmotic stress rather than global defects in cell division. Unlike tunicamycin, targocil does not sensitize MRSA strains to betalactams; however, subinhibitory concentrations of beta-lactams suppress the development of targocil-resistant mutants. These observations and their implications for the use of WTA-active antibiotics are discussed.
MATERIALS AND METHODS
Growth conditions for electron microscopy samples. S. aureus SH1000, a fully sequenced methicillin-sensitive derivative of NCTC8325 (51) in which a defect in the alternative sigma factor sigB has been corrected (26) , was used in the present study. A single colony of S. aureus SH1000 was inoculated into tryptic soy broth (TSB) and shaken overnight at 30°C. This overnight culture was then diluted 1/500 into 60 ml of fresh TSB and shaken at 37°C for 2 h (optical density at 600 nm [OD 600 ] of ϳ0.17). The culture was split into 10 5-ml aliquots, each in a 50-ml conical tube. Targocil (5.0 g/ml, 8ϫ MIC) was added to half of the cultures, which continued to shake at 37°C until harvesting. Samples were spun down (7,500 ϫ g, 8 min) each hour following compound treatment (at 1, 2, 3, 4, and 8 h). Pellets were resuspended in 0.25 ml of TSB, and 0.25 ml of glutaraldehyde fixative solution was added to the sample. After 30 min at room temperature, the fixed samples were spun down and submitted to the Harvard Medical School EM Facility for further processing.
Autolysis procedure. Autolysis experiments were performed as described previously (35) . Briefly, an overnight culture of S. aureus SH1000 was diluted 1/100 into TSB (20 ml) in six 100-ml Erlenmeyer flasks and grown at 37°C to an OD 600 of ϳ0.3. Cultures of four flasks were treated with 8ϫ MIC of targocil dissolved in dimethyl sulfoxide (DMSO). A similar volume of DMSO (2%) was added to the other two flasks as a control. After 30 min, two control and two targocil-treated cultures were harvested by centrifugation. Two targocil-treated culture flasks were harvested after 120 min. The cells were washed by suspending in cold sterile water, followed by centrifugation. The cell pellets were resuspended in 0.05 M Tris-Cl (pH 7.2) containing 0.05% (vol/vol) Triton X-100 to an OD 600 of ϳ0.6. The cell cultures were incubated at 37°C with shaking, and the OD 600 was determined at 30-min intervals.
Growth conditions for microarray analysis. For transcriptional profiling, an overnight S. aureus SH1000 culture was diluted (2% [vol/vol]) into 20 ml of TSB medium in a 50-ml Erlenmeyer flask and grown at 37°C with shaking at 200 rpm. For the targocil treatment experiments, S. aureus was grown to an OD 600 of ϳ0.4 and challenged with 8ϫ MIC of targocil dissolved in DMSO for 30 min. Simultaneously, an equal amount of DMSO (final concentration 2% [vol/vol]) was added to the control culture, which was incubated along with the treated cultures. After 30 min, 5-ml aliquot was collected and used as a control for the 30-min treated culture.
RNA preparation and probe synthesis. For total RNA extraction, 5 ml of culture was used and mixed with 5 ml of bacterial RNA Protect solution (Qiagen, Valencia, CA) and was further processed, and probes were synthesized as described by Muthaiyan et al. (46) . Three independent bacterial cultures were prepared as biological replicates for RNA isolation of both test and control samples.
Microarray hybridization, processing, and data analysis. Labeled c-DNA was hybridized with S. aureus Genome Microarray (version 7.0), provided by the Pathogen Functional Genomics Resource Center of the National Institutes of Allergy and Infectious Diseases, National Institutes of Health. The full genome array consists of 4,589 open reading frames (ORFs) from S. aureus reference strains COL, Mu50, MW2, N315, MRSA252, USA300-FPR3757, and pLW043 (http://pfgrc.jcvi.org/index.php/microarray/array _description/staphylococcus_aureus/version7.htmL). Each ORF is printed in four replicates on the array. Hybridization signals were scanned, and fold changes in gene expression were calculated as described previously (46) . A cutoff of 2.0-fold for over-and underexpressed ORFs was used except where noted. The gene data sets were found to be significant at a false discovery rate of Ͻ1% (i.e., q Ͻ 0.01 [q represents the estimated probability of a false positive]). Genes with altered transcription levels were functionally categorized using our in-house Gene Sorter software according to the categories described in the comprehensive microbial resource of TIGR (http://cmr.tigr.org /tigr-scripts/CMR/shared/Genomes.cgi). The data discussed here will be available in NCBI's Gene Expression Omnibus (GEO) under accession number GSE34441.
RESULTS
Effects of targocil on S. aureus growth and morphology. The targocil MIC against most S. aureus strains is about 1 g/ml (36, 63). Based on counting CFUs as a function of time, we previously reported that targocil has bacteriostatic activity against S. aureus (36, 62, 63) . Since then, we have found that the OD 600 of S. aureus does not remain constant following the addition of targocil to exponentially growing cultures but continues to rise gradually, albeit at a greatly reduced rate compared to the untreated control. Hence, the biomass of cultures treated with targocil increases even though the number of viable colonies does not change (see Fig. S1 in the supplemental material).
We used TEM to characterize the effects of targocil on the morphology of S. aureus SH1000, a methicillin-sensitive strain (see Materials and Methods). Samples were isolated each hour for 8 h from cultures of exponentially growing S. aureus SH1000 treated with targocil, and TEM images were acquired for each sample ( Fig. 2 and see Fig. S2 in the supplemental material). After 2 h, septa are present in 26.1% Ϯ 2.6 of wild-type cells but in 67.4% Ϯ 4.4 of targocil-treated cells. This observation initially suggested a block in cell division. However, after 2 h we observed clusters of cells encased in a continuous layer of dark-staining surface material in the targocil-treated samples (Fig. 2) . The number of cells in each cluster increased over time, and the septal material became thicker but stained more lightly, suggesting decreased levels of electron dense WTAs (43) . The cells also increased in size, with the average area of individual cells doubling within 4 h (wild type, 0.02 Ϯ 0.002; treated [no septa], 0.05 Ϯ 0.005; treated [septa], 0.082 Ϯ 0.02). Based on the TEM studies, we concluded that the increased biomass observed by OD 600 measurement is due to increased cell size and slow ongoing cell division, which is not reflected in increased CFUs because daughter cell separation is severely impaired (see Fig. S3 and Table S1 in the supplemental material).
Effects of targocil on autolytic activity. Autolysins are cell wall-degradative enzymes required for cell division in S. aureus (71) . They facilitate cell separation following division by degrading old PG. Triton X-100 induces autolysin activity in S. aureus by unknown mechanisms, and this is detected as a decrease in OD 600 as the cells lyse (24) . Since cell separation is impaired in targociltreated cells, we tested the effects of targocil on induced autolytic activity. Cultures of S. aureus SH1000 were treated with targocil for 30 or 120 min, and then the cells were transferred to buffer containing Triton X-100. Whereas untreated cells were fully lysed within 2 h, targocil-treated cells showed minimal lysis after 2 h (Fig. 3 ). Since cell separation requires activation of autolytic enzymes, the decreased autolytic activity upon Triton X-100 treatment is consistent with the TEM images showing that daughter cell separation is inhibited.
Effects of targocil on gene transcripts level in S. aureus. Gene expression profiling studies in S. aureus SH1000 were performed to identify genes for which transcript levels changed significantly upon targocil treatment (i.e., up-or downregulated genes). Microarray analysis was carried out after 30 min of targocil treatment, and the data reported represent the averages of three independent biological replicates. A total of 119 genes were upregulated at least 2-fold after 30 min, whereas 96 genes were downregulated (Tables 1 and 2; see also Tables S2 and S3 in the supplemental material). Excluding genes of unknown or hypo- thetical function, the major categories encode proteins involved in transport and binding, cell envelope, energy metabolism, cellular processes, regulatory functions, protein fate, nucleotide synthesis, and central metabolism (Fig. 4) . Within each category, the number of genes up-and downregulated is similar except in the protein fate category, which contains almost exclusively upregulated genes. The pattern of significantly affected and minimally affected categories is consistent with the effects of a molecule that targets the cell wall. This conclusion is supported by more detailed analysis of specific changes, which are described below. Cell envelope genes. Cell wall-active antibiotics induce characteristic changes in numerous genes that comprise the "cell wall stress stimulon" (30, 34, 64) . Many of these genes are regulated by a two-component system composed of a sensor, VraS, and a response regulator, VraR, which correspond to LiaRS in the model organism B. subtilis (41, 42) . Targocil treatment upregulated both the vraR and vraS genes ( Table 1) . Correlated changes in other cell wall stress stimulon genes were also observed upon targocil treatment (Table 1) . For example, cwrA, a very sensitive reporter of cell wall stress, which encodes a small peptide of unknown function, was upregulated by 26.5-fold (5, 44). The sgtB gene, which encodes a monofunctional glycosyltransferase involved in PG biosynthesis and is known to be induced by cell wall stress (34) , was also upregulated. Other upregulated cell envelope-related genes include the following: SAV0212, a predicted peptidase; fmt, a gene implicated in both methicillin resistance and regulation of autolysis; pbp2, the sole essential class A penicillin-binding protein in S. aureus; and murZ, a UDP-N-acetylglucosamin-1-carboxyvinyl transferase that catalyzes the first committed step in PG precursor synthesis. Unlike typical cell wall-active antibiotics, targocil treatment also upregulates a number of WTA pathway genes in addition to PG synthesis genes (Table 1) . These genes include the CDP-glycerol-3-phosphate primase tarF, a CDP-ribitol-5-phosphate polymerase tarK (55, 56) , and tarGH, which encode the two-component ABC transporter that exports WTAs to the cell surface. TarG is the target of targocil (36, 58, 63) . The upregulation of a number of WTA genes is consistent with the proposal that targocil blocks the maturation of WTAs (58, 63) .
Genes involved in virulence factor expression or synthesis. S. aureus expresses a large number of nonessential proteins, polysaccharides, lipids, and small molecules that have been implicated in virulence (8, 17) . Analysis of the transcriptome shows that targocil downregulates several genes encoding transcription factors involved in virulence factor production ( Table 2 ). These downregulated transcription factor genes include sarR (staphylococcal accessory regulator R), agrA (accessory gene regulator A), arlR (a DNA-binding response regulator R), and rsbV (anti anti-sigma factor V) (1, 7, 18, 53) . In S. aureus, the agr operon is expressed as a single polycistronic unit and other genes of this operon, agrC2, agrB, and agrD are also moderately downregulated upon targocil treatment (see Table S3 in the supplemental material). The downregulation of some of these transcription factor genes may explain decreased expression of several virulence genes including a probable adhesin, SAV0631, the lipase geh and staphylococcal protein A.
Targocil treatment also reduces the expression of capsular polysaccharide genes including capA, capF, capH, capL, and cap5M (Table 2) . Although changes in the levels of capsule gene mRNA levels were modest (ranging from Ϫ1.9-to Ϫ2.4-fold), similar values were observed for multiple genes in the operon, indicating a consistent association between targocil treatment and decreased capsule production. Capsule is important for the efficient colonization and infection of certain animal models (6) . The cap genes may be downregulated due to reduced expression of arlR and agrA during an SOS response (11) . ClpC has also been shown to repress capsule production (39) , and its expression is upregulated in the targocil transcriptome ( Table 1 ). The dlt-ABCD operon showed similar reductions in gene expression (ranging from Ϫ1.7-to Ϫ3.3-fold), which also supports a func- 
FIG 4
Numbers of genes in major categories affected after 30 min of targocil treatment (up/down). Fewer than 15 genes involved in central intermediary metabolism (11/2) and purine/pyrimidine biosynthesis (1/13) were affected; categories are not displayed. No significant changes were observed in the expression of genes responsible for amino acid biosynthesis, cofactor biosynthesis, DNA metabolism, fatty acid and phospholipid synthesis, protein synthesis, signal transduction, or transcription, and these categories are not displayed.
tional connection between targocil treatment and cell wall changes ( Table 2 ). The products of the dlt genes catalyze Dalanylation, a tailoring modification of both lipoteichoic acids and WTAs that has been implicated in animal infection, colony spreading, and resistance to cationic antibiotics (31, 56, 69) . Due to the roles of D-alanylation in virulence, the enzymes in the D-alanylation pathway are proposed therapeutic targets, and downregulation of the dlt genes is a potentially advantageous feature of late stage WTA inhibitors. The staphyloxanthin biosynthetic genes ctrM and ctrN were also modestly downregulated (Ϫ1.9-and Ϫ1.5-fold, respectively; Table 2 ), and the cell pellets following targocil treatment had lost their characteristic golden color, which is due to staphyloxanthin production (see Fig. S4 in the supplemental material) . Staphyloxanthin is a carotenoid that increases fitness by protecting S. aureus from oxidative stress and neutrophil-based killing (12) and, since its loss increases the susceptibility of S. aureus to innate immune clearance in a mouse infection model (38, 50) , staphyloxanthin biosynthesis is a proposed anti-virulence factor target.
Protein fate genes. A major category of affected genes are those involved in protein folding and degradation, which are almost exclusively upregulated in the targocil transcriptome (Table 1) . These include the following genes: grpE, dnaJ, and dnaK, which encode proteins that work together to prevent the aggregation of stress-denatured proteins (49); clpB, groES, and groEL, which encode proteins that help ensure the proper folding of nascent peptides (16, 19) ; clpC, which encodes a protease that degrades denatured proteins (37); and psrA, which encodes a peptidylprolyl-cis-trans isomerase that participates in protein folding (23, 25) . Genes that regulate protein fate genes also show increased expression. For example, mcsB, a gene encoding an unusual arginine kinase that negatively regulates the stress gene repressor CtsR, is highly upregulated (21) . Likewise, the gene encoding the heat-inducible transcriptional repressor HcrA, which coordinates the expression of many of these protein quality control elements (47) is also upregulated. Although PG biosynthesis inhibitors also induce a heat shock-like stress response due to a proposed accumulation of misfolded and aberrant proteins (2), the response to targocil treatment is particularly strong and suggests that misfolded and aberrant proteins may accumulate to a greater extent upon targocil treatment than other cell wall-active antibiotics. Alternatively, the accumulated WTA polymers may be sensed as defective/misfolded proteins.
Transport/binding proteins. Genes responsible for transport and binding proteins make up the largest functional category in S. aureus (other than hypothetical proteins), and the greatest number of gene expression changes occurs in this category upon targocil treatment (Fig. 4) . For example, the expression of hrtA and hrtB, which encode a two-component ABC exporter putatively involved in hemin efflux, are each increased 12.7-fold. These genes modulate virulence, prevent toxicity due to the accumulation of hemin, and redirect central metabolism to increase iron availability (3, 29) . Genes SAS0283, SAV0838, and SAV2450, encoding several putative amino acid transporters, are also upregulated. The genes opuCB and opuCC encoding the compatible solute glycine betaine and carnitine transporters are upregulated as well (Table 1) .
Transport genes negatively affected by targocil treatment include the following: the uracil permease gene pyrP and its regulator, pyrR; pbuX (xanthin permease), the fructose-specific transporter; SACOL0689 (metal cation ABC transporter permease); and nhaC (Na ϩ /H ϩ antiporter). Genes encoding the phosphotransferase system, SAS0665 (fructose specific) and glcA (glucose specific) are also downregulated. Changes in the expression of transport genes are observed with other cell wall-active antibiotics and suggest altered envelope integrity.
Metabolism and other genes. Some electron transport genes are upregulated in S. aureus upon targocil treatment. For example, ndhF and SAV2536 transcript levels increase 4.3-and 2.8-fold, respectively. The product of ndhF protects bacteria from oxidative stress and has been implicated in a theory that links bacterial killing by antibiotics to oxidative stress (33) . Several urease pathway genes are also upregulated ( Table 2 ). These genes function to produce ammonia and could be acting to neutralize and/or buffer the negatively charged polymers accumulating within the cell upon TarG inhibition.
Subinhibitory concentrations of beta-lactams suppress the development of targocil resistance. We have previously reported that inhibiting TarO with tunicamycin restores beta-lactam sensitivity to MRSA (10) . For example, the MIC of oxacillin decreases by 128-fold in some MRSA strains when WTA synthesis is blocked (10) . To determine whether late-stage inhibition of WTA synthesis also sensitizes MRSA strains to beta-lactams, we tested the oxacillin MICs of several MRSA strains in the presence of targocil using a checkerboard assay (data not shown). Synergy was not observed in the checkerboard assay since the MICs for each compound remained unchanged. Despite the lack of synergy, however, we observed that oxacillin concentrations 5-fold below the MIC suppressed the growth of targocil-resistant mutants in culture plates over a period of several days. This effect was recapitulated on agar plates. For example, when MRSA strains 1784A and MW2 were streaked onto plates containing targocil at 8ϫ MIC, resistant mutants grew at high frequencies (Ͼ1 in 10 6 CFUs). However, no colonies were visible if oxacillin at 0.2ϫ MIC (5 g/ml) was also included in the plates, even though a lawn of MRSA is typically observed at this beta-lactam concentration ( Fig.  5 and see Fig. S5 in the supplemental material). We conclude from these observations that beta-lactams suppress the development of targocil-resistant mutants in MRSA strains.
DISCUSSION
New antibacterials to treat MRSA infections are desperately needed, and the WTA biosynthetic pathway is a proposed target for such agents. Genetic studies have identified two possible classes of targets in the pathway: (i) antivirulence targets that are not essential but affect pathogenicity and (ii) antibacterial targets that are essential (10, 15, 36, 62, 63, 67) . Specific inhibitors of members of both classes of targets are available, and we have been investigating the pharmacological effects of blocking early and late steps of WTA synthesis using expression analysis and phenotypic characterization.
In previous work we showed that tunicamycin, which blocks the first step in the WTA pathway, causes profound morphological defects even though it does not significantly affect in vitro growth rates and has only a modest effect on gene expression (10) . The morphological defects include aberrations in septal placement, a high frequency of duplicate septa, and an inability to separate following the completion of new septa. These defects imply that WTAs are required for properly coordinated cell division and suggest a link between PG and WTA biosynthesis. Properly regu-lated cell division is important for viability under stressful conditions and the extent of the cell division defects may help to explain why S. aureus ⌬tarO strains are avirulent in animal models.
We have examined here the effects of a late-stage WTA inhibitor on S. aureus. This inhibitor, targocil, is a synthetic small molecule that was identified through high-throughput screening (36, 63) . Unlike tunicamycin, targocil inhibits bacterial growth by affecting PG biosynthesis and also induces a strong cell wall stress response. For example, many genes in the cell wall stress stimulon are upregulated. Since tunicamycin does not have a similar effect on gene expression at the concentrations required to inhibit TarO (10), the observed cell wall stress response is not a result of preventing WTA expression, but of blocking its maturation at a late stage. Such a block would lead to the accumulation of bactoprenol-linked intermediates and prevent recycling of the bactoprenol phosphate carrier lipid (15) , which is also required for PG biosynthesis. Since an intact PG layer is required for cell survival, damage to the cell envelope occurs over time if PG precursor pools are limited.
In addition to affecting the cell wall stress stimulon, targocil treatment upregulates "heat shock" genes such as groES, groEL, and grpE, which are involved in protein quality control. It is known that induction of heat shock proteins decreases the rate of autolysis in S. aureus cells (57) . Furthermore, in Listeria monocytogenes, induction of a heat shock response leads to downregulation of both cell division genes and autolysins, preventing cell division (65) . We observed significant decreases in both autolytic activity and cell division in S. aureus upon targocil treatment. These effects may be linked to the observed induction of a strong "heat shock-like" stress response.
Targocil treatment also downregulates genes involved in the production of several virulence factors, including capsule. Capsule is a nonessential cell wall glycopolymer that plays an important role in S. aureus pathogenesis (52) . Like PG and WTAs, capsule is synthesized on the bactoprenol carrier lipid (72) . The downregulation of genes involved in capsule formation may reflect an attempt to conserve the carrier lipid for use in the essential process of PG biosynthesis. This explanation could also be consistent with the observed downregulation of staphyloxanthin biosynthetic genes since staphyloxanthin is produced from a polyisoprenoid intermediate (54) . We speculate that S. aureus has a mechanism for sensing PG precursor and can downregulate nonessential molecules that utilize the carrier lipid or its building blocks to ensure flux into PG synthesis. Downregulation of capsule may be a useful aspect of late stage WTA inhibitors.
In addition to examining changes in gene expression, cell morphology, and autolytic activity upon blocking TarG, we have also looked at the effects on MRSA of combining targocil with a betalactam. Although the TarO inhibitor tunicamycin strongly sensitizes MRSA to beta-lactams, no synergy between targocil and betalactams was found in a checkerboard assay. Since beta-lactams are known to be effective only against rapidly growing cells, the lack of synergy reflects targocil's growth-inhibitory activity. However, we observed that resistant mutants appear at a greatly reduced frequency when targocil is used in combination with oxacillin. A major mechanism by which resistance arises to targocil in vitro is through null mutations in tarO and tarA, which encode the first two, nonessential genes in the WTA biosynthetic pathway. We have previously shown that blocking TarO in MRSA strains restores beta-lactam susceptibility. Beta-lactams may suppress the formation of targocil resistance by eliminating the tarO/A-null mutant population (58, 63) . Another mechanism for resistance suppression may be related to the viability of multicellular clusters in the presence of beta-lactams. We have shown that S. aureus cells continue to divide very slowly without separating in the presence of targocil alone. Resistant mutants may emerge from cells within the resulting multicellular clusters. If simultaneous beta-lactam treatment reduces the viability/growth of these clusters, e.g., by further weakening the cell wall due to dysregulated synthetic and degradative activity, then mutants may not emerge. Regardless of the mechanism, the finding implies that the combined use of beta-lactams and targocil may be useful in limiting the spread of resistance.
Conclusions. The findings reported here show that targocil, the first identified late-stage inhibitor of WTA biosynthesis, acts as a cell wall-active antibiotic. It causes damage to the cell envelope, probably due to an inhibitory effect on PG biosynthesis since the bactoprenol carrier lipid is sequestered in WTA intermediates. It also induces a strong heat shock-like stress response due to the accumulation of misfolded proteins and the possible missensing of WTA intermediates as damaged proteins. Targocil decreases expression of several virulence factor genes and their regulators, which may be advantageous for its use in vivo. Finally, although beta-lactams do not synergize with targocil, as they do with the TarO inhibitor tunicamycin, subinhibitory concentrations of beta-lactams suppress the formation of targocil resistant mutants. Based on these results, we propose that the combined effects of a late-stage WTA inhibitor may lead to effective killing of S. aureus, particularly when used in combination with a beta-lactam. 
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